Skip to content
Search

Latest Stories

operation warp speed

Grading President Biden's first 100 days; 2020 US Census helps Sun Belt states
US Politics In 60 Seconds

Grading President Biden's first 100 days; 2020 US Census helps Sun Belt states

How would you grade President Biden's performance in his first 100 days? Who are the winners and losers from the 2020 US census results? Get insights on the latest news in US politics from Jon Lieber, head of Eurasia Group's coverage of political and policy developments in Washington.

Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?
GZERO World Clips

Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?

Without the help of the US government initiative "Operation Warp Speed," Moderna co-founder Noubar Afeyan says that it would have been impossible for the company to develop and deliver its vaccine so quickly. The fact, he says, that the American people may be days away from receiving its first doses is, in large part, thanks to their taxpayer dollars. Does President Trump, himself, deserve credit? "Without caveat," Afeyan says. He spoke with Ian Bremmer on GZERO World.

Ambassador Shea on AI risks, US-China ties and Lebanon
UN General Assembly

Ambassador Shea on AI risks, US-China ties and Lebanon

On the sidelines of the 81st UN General Assembly in New York at GZERO and Microsoft's innagural Global Stage Cafe, Ambassador Dorothy Shea, who previously served as US chargé d'affaires and acting representative to the United Nations, sits down with Tony Maciulis to unpack the debate over AI regulation, US-China relations and Lebanon's security future.

How development of the COVID-19 vaccine shattered records
GZERO World Clips

How development of the COVID-19 vaccine shattered records

They said it couldn't be done: a vaccine developed in record time. In 1967, Merck had a license for a mumps vaccine, less than five years for work that normally takes decades. But that record is now being shattered as the COVID-19 vaccine reaches the market in less than a year. It's an unprecedented scientific development in a whirlwind year of crisis.

Quick Take: Latest vaccine news may be a light at the end of the tunnel
Quick Take

Quick Take: Latest vaccine news may be a light at the end of the tunnel

Ian Bremmer's Quick Take:



Hey, everybody. Ian Bremmer here, happy Monday, Thanksgiving week. Things starting to look increasingly normal in terms of outlook, in terms of having all of these vaccines. I understand that the next few months in the United States are going to be incredibly challenging, but so much easier when you see that there's light at the end of the tunnel and you know where that's coming. Most recently, the AstraZeneca announcement, which for me, in some ways is a bigger deal globally, even than what we've seen from Moderna and Pfizer.